M Bai

549 total citations
18 papers, 393 citations indexed

About

M Bai is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Bai has authored 18 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Bai's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers) and Cancer-related Molecular Pathways (3 papers). M Bai is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers) and Cancer-related Molecular Pathways (3 papers). M Bai collaborates with scholars based in Greece, Netherlands and Australia. M Bai's co-authors include A. A. Drosos, Panagiotis Kanavaros, Niki J. Agnantis, Paraskevi V. Voulgari, Vasiliki Galani, Elena Tsanou, Sevasti Kamina, Dimitrios Assimakopoulos, Natasha Jiwa and W Vos and has published in prestigious journals such as The Lancet, Oncogene and British Journal of Cancer.

In The Last Decade

M Bai

18 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Bai Greece 13 151 117 94 92 52 18 393
Oliver Wengert Germany 8 98 0.6× 148 1.3× 82 0.9× 148 1.6× 142 2.7× 10 501
Anna Olewicz‐Gawlik Poland 11 40 0.3× 108 0.9× 75 0.8× 56 0.6× 70 1.3× 31 338
F Tanda Italy 12 154 1.0× 164 1.4× 57 0.6× 159 1.7× 34 0.7× 44 462
Marta S. Gallego Argentina 15 82 0.5× 61 0.5× 40 0.4× 228 2.5× 39 0.8× 43 644
Erika Lerch Switzerland 9 63 0.4× 65 0.6× 48 0.5× 62 0.7× 33 0.6× 19 510
L.C.S. Thuler Brazil 11 65 0.4× 50 0.4× 44 0.5× 56 0.6× 36 0.7× 16 291
Matthew Pugh United Kingdom 13 119 0.8× 70 0.6× 37 0.4× 68 0.7× 73 1.4× 29 328
A. Sztankay Austria 12 89 0.6× 99 0.8× 51 0.5× 68 0.7× 34 0.7× 20 529
Ioanna Ε. Stergiou Greece 12 52 0.3× 49 0.4× 77 0.8× 158 1.7× 47 0.9× 41 358
Mila Jhamai Netherlands 10 111 0.7× 204 1.7× 43 0.5× 250 2.7× 30 0.6× 13 612

Countries citing papers authored by M Bai

Since Specialization
Citations

This map shows the geographic impact of M Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bai more than expected).

Fields of papers citing papers by M Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bai. The network helps show where M Bai may publish in the future.

Co-authorship network of co-authors of M Bai

This figure shows the co-authorship network connecting the top 25 collaborators of M Bai. A scholar is included among the top collaborators of M Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Bai. M Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhao, Tianyu, M Bai, Renheng Wang, et al.. (2024). [Prognostic value and imaging features of (18)F-FDG PET-CT in follicular lymphoma with different histopathology grade].. PubMed. 45(8). 776–780. 2 indexed citations
2.
Bai, M, Robert G. Parton, Ingrid Hoffmann, et al.. (2012). RhoD participates in the regulation of cell-cycle progression and centrosome duplication. Oncogene. 32(14). 1831–1842. 19 indexed citations
3.
Kalimeris, Konstantinos, Petros Karakitsos, Anna Batistatou, et al.. (2011). Influence of propofol and volatile anaesthetics on the inflammatory response in the ventilated lung. Acta Anaesthesiologica Scandinavica. 55(6). 740–748. 33 indexed citations
4.
Syed, Nelofer, Paul J. Smith, Beverly E. Griffin, et al.. (2010). DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma. British Journal of Cancer. 103(2). 265–274. 25 indexed citations
5.
Kalambokis, Georgios, et al.. (2005). Multiple brown tumors of the ribs simulating malignancy. Journal of Endocrinological Investigation. 28(10). 738–740. 9 indexed citations
6.
Voulgari, Paraskevi V., et al.. (2005). Laryngeal involvement in rheumatoid arthritis. Rheumatology International. 25(5). 321–325. 39 indexed citations
7.
Drosos, A. A., et al.. (2004). Sinus histocytosis with massive lymphadenopathy (Rosai–Dorfman disease) in a patient with primary Sjogren's syndrome. Scandinavian Journal of Rheumatology. 33(2). 119–122. 4 indexed citations
8.
Bai, M, Niki J. Agnantis, Elena Tsanou, et al.. (2003). Increased Expression of the bcl6 and CD10 Proteins Is Associated with Increased Apoptosis and Proliferation in Diffuse Large B-Cell Lymphomas. Modern Pathology. 16(5). 471–480. 47 indexed citations
9.
Bai, M, Elena Tsanou, Niki J. Agnantis, et al.. (2003). Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas.. PubMed. 18(2). 449–57. 15 indexed citations
10.
Katsaraki, Afroditi, et al.. (2001). The in vivo cell kinetics in breast carcinogenesis. Breast Cancer Research. 3(S1). 276–83. 31 indexed citations
11.
Kanavaros, Panagiotis, Kalliopi Stefanaki, Dimitra Rontogianni, et al.. (2001). Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.. PubMed. 16(4). 1005–12. 35 indexed citations
12.
Kanavaros, Panagiotis, Kalliopi Stefanaki, John Vlachonikolis, et al.. (2001). Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.. PubMed. 20(6B). 4619–25. 17 indexed citations
13.
Drosos, A. A., Paraskevi V. Voulgari, D. Psychos, Niki Tsifetaki, & M Bai. (1999). Sicca syndrome in patients with sarcoidosis. Rheumatology International. 18(5-6). 177–180. 32 indexed citations
14.
Skevas, A, et al.. (1997). Old-world leishmaniasis of the auricle. The Lancet. 349(9044). 28–29. 8 indexed citations
15.
Gossios, K., et al.. (1996). Widespread Castleman disease: CT findings. European Radiology. 6(1). 95–98. 5 indexed citations
16.
17.
Bai, M, Natasha Jiwa, A Horstman, et al.. (1994). Decreased expression of cellular markers in Epstein‐Barr virus‐positive Hodgkin's disease. The Journal of Pathology. 174(1). 49–55. 29 indexed citations
18.
Pavlidis, Nicholas, Evangelos Briassoulis, G. Klouvas, & M Bai. (1992). Is interferon-a an active agent in Castleman’s disease?. Annals of Oncology. 3(1). 85–86. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026